| 1. |
Weisenburger, D. D., Gordon, B. G., Vose, J. M., et al. (1996) Occurrence of the t(2;5)(p23;q35) in non-Hodgkin’s lymphoma.
Blood
87, 3860–3868.
|
| |
| 2. |
Jaffe, E. S. (2001) Anaplastic large cell lymphoma: the shifting sands of diagnostic hematopathology. Mod. Pathol.
14, 219–228.
|
| |
| 3. |
Dyomin, V. G., Rao, P. H., Dalla-Favera, R., and Chaganti, R. S. (1997) BCL8, a novel gene involved in translocations affecting band 15q11–13 in diffuse large-cell lymphoma. Proc. Natl. Acad. Sci. USA
94, 5728–5732.
|
| |
| 4. |
Gilles, F., Goy, A., Remache, Y., Shue, P., and Zelenetz, A. D. (2000) MUC1 dysregulation as the consequence of a t(1;14)(q21;q32) translocation in an extranodal lymphoma. Blood
95, 2930–2936.
|
| |
| 5. |
Juneja, S., Lukeis, R., Tan, L., et al. (1990) Cytogenetic analysis of 147 cases of non-Hodgkin’s lymphoma: nonrandom chromosomal
abnormalities and histological correlations. Br. J. Haematol.
76, 231–237.
|
| |
| 6. |
Fukuhara, S., Rowley, J. D., Variakojis, D., and Golomb, H. M. (1979) Chromosome abnormalities in poorly differentiated lymphocytic
lymphoma. Cancer Res.
39, 3119–3128.
|
| |
| 7. |
Horsman, D. E., Connors, J. M., Pantzar, T., and Gascoyne, R. D. (2001) Analysis of secondary chromosomal alterations in 165
cases of follicular lymphoma with t(14;18). Genes Chromosomes Cancer
30, 375–382.
|
| |
| 8. |
Cuneo, A., Bigoni, R., Rigolin, G. M., et al. (1999). Cytogenetic profile of lymphoma of follicle mantle lineage: correlation
with clinicobiologic features. Blood
93, 1372–1380.
|
| |
| 9. |
Sawyer, J. R., Waldron, J. A., Jagannath, S., and Barlogie, B. (1995) Cytogenetic findings in 200 patients with multiple myeloma.
Cancer Genet. Cytogenet.
82, 41–49.
|
| |
| 10. |
Li, J-Y., Gaillard, F., Moreau, A., et al. (1999) Detection of translocation t(11;14)(q13;q32) in mantle cell lymphoma by
fluorescence in situ hybridization. Am. J. Pathol.
154, 449–1452.
|
| |
| 11. |
Troussard, X., Mauvieux, L., Radford-Weiss, I., et al. (1998) Genetic analysis of splenic lymphoma with villous lymphocytes:
A Groupe Francais d’Hematologie Cellulaire (GFHC) study. Br. J. Haematol.
101, 712–721
|
| |
| 12. |
Oscier, D. G., Matutes, E., Gardiner, A., et al. (1993) Cytogenetic studies in splenic lymphoma with villous lymphocytes.
Br. J. Haematol.
85, 487–491.
|
| |
| 13. |
Oscier, D. G., Gardiner, A., and Mould, S. (1996) Structural abnormalities of chromosome 7q in chronic lymphoproliferative
disorders. Cancer Genet. Cytogenet.
92, 24–27
|
| |
| 14. |
Caraway, N. P., Du, Y., Zhang, H-Z., Hayes, K., Glassman, A. B., and Katz, R. L. (2000) Numeric chromosomal abnormalities
in small lymphocytic and transformed large cell lymphomas detected by fluorescence in situ hybridization of fine-needle aspiration
biopsies. Cancer
90, 126–132.
|
| |
| 15. |
Offit, K., Parsa, N. Z., Filippa, D., Jhanwar, S. C., and Chaganti, R. S. K. (1992) t(9;14)(p13;q32) denotes a subset of low-grade
non-Hodgkin’s lymphoma with plasmacytoid differentiation. Blood
80, 2594–2599.
|
| |
| 16. |
Schlegelberger, B., Zwingers, T., Hohenadel, K., et al. (1996) Significance of cytogenetic findings for the clinical outcome
in patients with T-cell lymphoma of angioimmunoblastic lymphadenopathy type. J. Clin. Oncol.
14, 593–599.
|
| |
| 17. |
Atkin, N. B. (1998) Cytogenetics of Hodgkin’s disease. Cytogenet. Cell Genet.
80, 23–27.
|
| |
| 18. |
Kaneko, Y., Frizzera, G., Maseki, N., Sakurai, M., Komada, Y., et al. (1988) A novel translocation, t(9;17)(q34;q23), in aggressive
childhood lymphoblastic lymphoma. Leukemia
2, 745–748.
|
| |
| 19. |
Shikano, T., Arioka, H., Kobayashi, R., et al. (1994) Acute lymphoblastic leukemia and non-Hodgkin’s lymphoma with mediastinal
mass-a study of 23 children; different disorders or different stages? Leukemia Lymphoma
13, 161–167.
|
| |
| 20. |
Juliusson, G., Oscier, D. G., Fitchett, M., et al. (1990) Prognostic subgroups in B-cell chronic lymphocytic leukemia defined
by specific chromosomal abnormalities. N. Eng. J. Med.
323, 720–724.
|
| |
| 21. |
Lens, D., De Schouwer, P. J. J. C., Hamoudi, R. A., et al. (1997) p53 abnormalities in B-cell prolymphocytic leukemia. Blood
89, 2015–2023.
|
| |
| 22. |
Dohner, H., Stilgenbauer, S., Benner, A., et al. (2000) Genomic aberrations and survival in chronic lymphocytic leukemia.
N. Engl. J. Med.
343, 1910–1916.
|
| |
| 23. |
Dearden, C. E., Matutes, E., Cazin, B., et al. (2001) High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H.
Blood
98, 1721–1726.
|
| |
| 24. |
Sorour, A., Brito-Babapulle, V., Smedley, D., Yuille, M., and Catovsky, D. (2000) Unusual breakpoint distribution of 8p abnormalities
in T-prolymphocytic leukemia: a study with YACS mapping to 8p11-p12. Cancer Genet. Cytogenet.
121, 128–132.
|
| |
| 25. |
Zandecki, M., Bernardi, F., Genevieve, F., et al. (1997) Involvement of peripheral blood cells in multiple myeloma: chromosome
changes are the rule within circulating plasma cells but not within B lymphocytes. Leukemia
11, 1034–1039.
|
| |
| 26. |
Calasanz, M. J., Cigudosa, J. C., Odero, M. D., et al. (1997) Cytogenetic analysis of 280 patients with multiple myeloma and
related disorders: primary breakpoints and clinical correlations. Genes Chromosomes Cancer
18, 84–93.
|
| |
| 27. |
Weh, H. J., Bartl, R., Seeger, D., Selbach, J., Kuse, R., and Hossfeld, D. K. (1995) Correlations between karyotype and cytologic
findings in multiple myeloma. Leukemia
9, 2119–2122.
|
| |
| 28. |
Dewald, G. W., Kyle, R., Hicks, G. A., and Griepp, P. R. (1985) The clinical significance of cytogenetic studies in 100 patients
with multiple myeloma, plasma cell leukemia, or amyloidosis. Blood
66, 380–390.
|
| |
| 29. |
Smadja, N. V., Louvet, C., Isnard, F., et al. (1995) Cytogenetic study of multiple myeloma at diagnosis: comparison of two
techniques. Br. J. Haematol.
90, 619–624.
|
| |
| 30. |
Luc Lai, J., Zandecki, M., Mary, J. Y., et al. (1995) Improved cytogenetics in multiple myeloma: A study of 151 patients including
117 patients at diagnosis. Blood
85, 2490–2497.
|
| |
| 31. |
Tricot, G., Barlogie, B., Jagannath, S., et al. (1995) Poor prognosis in multiple myeloma is associated only with partial
or complete deletions of chromosome 13 or abnormalities involving 11q and not with other karyotype abnormalities. Blood
86, 4250–4256.
|
| |
| 32. |
Tricot, G., Sawyer, J. R., Jagannath, S., et al. (1997) Unique role of cytogenetics in the prognosis of patients with myeloma
receiving high-dose therapy and autotransplants. J. Clin. Oncol.
15, 2659–2666.
|
| |
| 33. |
Cuneo, A., Balsamo, R., Roberti, M. G., et al. (1996) Interleukin-3 plus interleukin-6 may improve chromosomal analysis of
multiple myeloma: Cytologic and cytogenetic evidence in thirty-four patients. Cancer Genet. Cytogenet.
90, 171–175.
|
| |
| 34. |
Brigaudeau, C., Trimoreau, F., Gachard, N., et al. (1997) Cytogenetic study of 30 patients with multiple myeloma: comparison
of 3 and 6 day bone marrow cultures stimulated or not by using a miniaturized karyotypic method. Br. J. Haematol.
96, 594–600.
|
| |
| 35. |
Seong, C., Delasalle, K., Hayes, K., et al. (1998) Prognostic value of cytogenetics in multiple myeloma. Br. J. Haematol.
101, 189–194.
|
| |
| 36. |
Sawyer, J. R., Lukacs, J. L., Thomas, E. L., et al. (2001) Multicolour spectral karyotyping identifies new translocations
and a recurring pathway for chromosome loss in multiple myeloma. Br. J. Haematol.
112, 167–174.
|
| |
| 37. |
Desikan, R., Barlogie, B., Sawyer, J., et al. (2000) Results of high-dose therapy for 1000 patients with multiple myeloma:
durable complete remissions and superior survival in the absence of chromosome 13 abnormalities. Blood
95, 4008–4010.
|
| |
| 38. |
Gutierrez, N. C., Hernandez, J. M., Garcia, J. L., et al. (2001) Differences in genetic changes between multiple myeloma and
plasma cell leukemia demonstrated by comparative genomic hybridization. Leukemia
15, 840–845.
|
| |